180 related articles for article (PubMed ID: 29414380)
1. Gene therapy mediated seizure suppression in Genetic Generalised Epilepsy: Neuropeptide Y overexpression in a rat model.
Powell KL; Fitzgerald X; Shallue C; Jovanovska V; Klugmann M; Von Jonquieres G; O'Brien TJ; Morris MJ
Neurobiol Dis; 2018 May; 113():23-32. PubMed ID: 29414380
[TBL] [Abstract][Full Text] [Related]
2. Anticonvulsant effects and behavioural outcomes of rAAV serotype 1 vector-mediated neuropeptide Y overexpression in rat hippocampus.
Noe F; Vaghi V; Balducci C; Fitzsimons H; Bland R; Zardoni D; Sperk G; Carli M; During MJ; Vezzani A
Gene Ther; 2010 May; 17(5):643-52. PubMed ID: 20220782
[TBL] [Abstract][Full Text] [Related]
3. Neuropeptide Y gene therapy decreases chronic spontaneous seizures in a rat model of temporal lobe epilepsy.
Noè F; Pool AH; Nissinen J; Gobbi M; Bland R; Rizzi M; Balducci C; Ferraguti F; Sperk G; During MJ; Pitkänen A; Vezzani A
Brain; 2008 Jun; 131(Pt 6):1506-15. PubMed ID: 18477594
[TBL] [Abstract][Full Text] [Related]
4. Hippocampal NPY gene transfer attenuates seizures without affecting epilepsy-induced impairment of LTP.
Sørensen AT; Nikitidou L; Ledri M; Lin EJ; During MJ; Kanter-Schlifke I; Kokaia M
Exp Neurol; 2009 Feb; 215(2):328-33. PubMed ID: 19038255
[TBL] [Abstract][Full Text] [Related]
5. Focal administration of neuropeptide Y into the S2 somatosensory cortex maximally suppresses absence seizures in a genetic rat model.
van Raay L; Jovanovska V; Morris MJ; O'Brien TJ
Epilepsia; 2012 Mar; 53(3):477-84. PubMed ID: 22220638
[TBL] [Abstract][Full Text] [Related]
6. Combinatorial gene therapy for epilepsy: Gene sequence positioning and AAV serotype influence expression and inhibitory effect on seizures.
Melin E; Andersson M; Gøtzsche CR; Wickham J; Huang Y; Szczygiel JA; Boender A; Christiansen SH; Pinborg L; Woldbye DPD; Kokaia M
Gene Ther; 2023 Aug; 30(7-8):649-658. PubMed ID: 37029201
[TBL] [Abstract][Full Text] [Related]
7. Neuropeptide Y suppresses absence seizures in a genetic rat model primarily through effects on Y receptors.
Morris MJ; Gannan E; Stroud LM; Beck-Sickinger AG; O'Brien TJ
Eur J Neurosci; 2007 Feb; 25(4):1136-43. PubMed ID: 17331209
[TBL] [Abstract][Full Text] [Related]
8. Translational approach for gene therapy in epilepsy: Model system and unilateral overexpression of neuropeptide Y and Y2 receptors.
Ledri LN; Melin E; Christiansen SH; Gøtzsche CR; Cifra A; Woldbye DP; Kokaia M
Neurobiol Dis; 2016 Feb; 86():52-61. PubMed ID: 26607785
[TBL] [Abstract][Full Text] [Related]
9. Adeno-associated virus-mediated expression and constitutive secretion of NPY or NPY13-36 suppresses seizure activity in vivo.
Foti S; Haberman RP; Samulski RJ; McCown TJ
Gene Ther; 2007 Nov; 14(21):1534-6. PubMed ID: 17713567
[TBL] [Abstract][Full Text] [Related]
10. Differential actions of NPY on seizure modulation via Y1 and Y2 receptors: evidence from receptor knockout mice.
Lin EJ; Young D; Baer K; Herzog H; During MJ
Epilepsia; 2006 Apr; 47(4):773-80. PubMed ID: 16650144
[TBL] [Abstract][Full Text] [Related]
11. Y5 neuropeptide Y receptor overexpression in mice neither affects anxiety- and depression-like behaviours nor seizures but confers moderate hyperactivity.
Olesen MV; Christiansen SH; Gøtzsche CR; Holst B; Kokaia M; Woldbye DP
Neuropeptides; 2012 Apr; 46(2):71-9. PubMed ID: 22342800
[TBL] [Abstract][Full Text] [Related]
12. Anticonvulsant and antiepileptogenic effects mediated by adeno-associated virus vector neuropeptide Y expression in the rat hippocampus.
Richichi C; Lin EJ; Stefanin D; Colella D; Ravizza T; Grignaschi G; Veglianese P; Sperk G; During MJ; Vezzani A
J Neurosci; 2004 Mar; 24(12):3051-9. PubMed ID: 15044544
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptide Y suppresses absence seizures in a genetic rat model.
Stroud LM; O'Brien TJ; Jupp B; Wallengren C; Morris MJ
Brain Res; 2005 Feb; 1033(2):151-6. PubMed ID: 15694919
[TBL] [Abstract][Full Text] [Related]
14. Combined gene overexpression of neuropeptide Y and its receptor Y5 in the hippocampus suppresses seizures.
Gøtzsche CR; Nikitidou L; Sørensen AT; Olesen MV; Sørensen G; Christiansen SH; Ängehagen M; Woldbye DP; Kokaia M
Neurobiol Dis; 2012 Jan; 45(1):288-96. PubMed ID: 21884793
[TBL] [Abstract][Full Text] [Related]
15. Long-term valproate treatment increases brain neuropeptide Y expression and decreases seizure expression in a genetic rat model of absence epilepsy.
Elms J; Powell KL; van Raay L; Dedeurwaerdere S; O'Brien TJ; Morris MJ
PLoS One; 2013; 8(9):e73505. PubMed ID: 24039965
[TBL] [Abstract][Full Text] [Related]
16. Anxiolytic-like effects after vector-mediated overexpression of neuropeptide Y in the amygdala and hippocampus of mice.
Christiansen SH; Olesen MV; Gøtzsche CR; Woldbye DP
Neuropeptides; 2014 Dec; 48(6):335-44. PubMed ID: 25267070
[TBL] [Abstract][Full Text] [Related]
17. Adeno-associated viral vector-induced overexpression of neuropeptide Y Y2 receptors in the hippocampus suppresses seizures.
Woldbye DP; Angehagen M; Gøtzsche CR; Elbrønd-Bek H; Sørensen AT; Christiansen SH; Olesen MV; Nikitidou L; Hansen TV; Kanter-Schlifke I; Kokaia M
Brain; 2010 Sep; 133(9):2778-88. PubMed ID: 20688813
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide Y Y1 receptor hippocampal overexpression via viral vectors is associated with modest anxiolytic-like and proconvulsant effects in mice.
Olesen MV; Christiansen SH; Gøtzsche CR; Nikitidou L; Kokaia M; Woldbye DP
J Neurosci Res; 2012 Feb; 90(2):498-507. PubMed ID: 21971867
[TBL] [Abstract][Full Text] [Related]
19. Seizure suppression by GDNF gene therapy in animal models of epilepsy.
Kanter-Schlifke I; Georgievska B; Kirik D; Kokaia M
Mol Ther; 2007 Jun; 15(6):1106-13. PubMed ID: 17387333
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y-stimulated [(35) S]GTPγs functional binding is reduced in the hippocampus after kainate-induced seizures in mice.
Elbrønd-Bek H; Olling JD; Gøtzsche CR; Waterfield A; Wörtwein G; Woldbye DP
Synapse; 2014 Oct; 68(10):427-36. PubMed ID: 24985894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
